Anette Sommer

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates with enzymatically cleavable groups
- Patent number 12,144,865
- Issue date Nov 19, 2024
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of cytotoxic active agents having enzymatically cleavable...
- Patent number 12,059,472
- Issue date Aug 13, 2024
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site specific homogeneous with KSP inhibitors
- Patent number 11,806,404
- Issue date Nov 7, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of cytotoxic active agents having enzymatically cleavable...
- Patent number 11,685,714
- Issue date Jun 27, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...
- Patent number 11,123,439
- Issue date Sep 21, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site specific homogeneous with KSP inhibitors
- Patent number 10,973,923
- Issue date Apr 13, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...
- Patent number 10,485,880
- Issue date Nov 26, 2019
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
- Patent number 10,022,453
- Issue date Jul 17, 2018
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20240043379
- Publication date Feb 8, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20230039341
- Publication date Feb 9, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS
- Publication number 20210252161
- Publication date Aug 19, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS
- Publication number 20200360531
- Publication date Nov 19, 2020
- Bayer Aktiengesellschaft
- Niels BÖHNKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20190351066
- Publication date Nov 21, 2019
- Bayer Aktiengesellschaft
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS
- Publication number 20190262463
- Publication date Aug 29, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...
- Publication number 20190077752
- Publication date Mar 14, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318438
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...
- Publication number 20180169256
- Publication date Jun 21, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES (ADCS) OF KSP INHIBITORS WITH AGLYCOSYLATE...
- Publication number 20180015176
- Publication date Jan 18, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) WITH KINESIN SPINDEL PROTEIN (KSP)
- Publication number 20160346402
- Publication date Dec 1, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF
- Publication number 20150023989
- Publication date Jan 22, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREA...
- Publication number 20090076098
- Publication date Mar 19, 2009
- Jens Hoffmann
- G01 - MEASURING TESTING

Anette Sommer

Person

Patents Grantslast 30 patents

Antibody drug conjugates with enzymatically cleavable groups

Prodrugs of cytotoxic active agents having enzymatically cleavable...

Site specific homogeneous with KSP inhibitors

Prodrugs of cytotoxic active agents having enzymatically cleavable...

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (AP...

Site specific homogeneous with KSP inhibitors

Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylate...

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

Patents Applicationslast 30 patents

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS

ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS

PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (AP...

ANTIBODY-DRUG CONJUGATES (ADCS) OF KSP INHIBITORS WITH AGLYCOSYLATE...

ANTIBODY DRUG CONJUGATES (ADCS) WITH KINESIN SPINDEL PROTEIN (KSP)

NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF

METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREA...